Rising Hospital Costs Driven by Consolidation; Competition Seen as Remedy
Hospital charges increased 5.2% as drug prices slipped, and analysts link the surge to market consolidation, calling for more competition and price transparency.
Recent federal statistics reveal a 3.1% decline in prescription drug prices, the sharpest drop in over sixty years, contrasted with a 5.2% rise in hospital fees. Hospital spending accounted for roughly $1.6 trillion of the $5.7 trillion total health-care outlay in 2024, and prices have climbed more than 220% since 2000. Analysts point to nearly 500 hospital mergers between 2016 and 2024, which have concentrated market power in the hands of a few large systems, driving price hikes of 20% to 50% in affected regions.
They recommend enforcing existing price-transparency mandates, adopting site-neutral Medicare payments, and repealing certificate-of-need laws to lower barriers for new entrants. Such steps aim to foster competition without imposing direct price controls, potentially curbing the rapid growth of medical inflation.
Why it matters
Hospital price growth affects a large share of health spending, so boosting competition could lower costs for patients and insurers.
In this story
